ABL Texcell Diagnostics SA (EPA:ABLD)
France · Delayed Price · Currency is EUR 2.200
0.00 (0.00%)
Oct 2, 2026, 4:44 PM CET
ABL Texcell Diagnostics Market Cap
ABL Texcell Diagnostics has a market cap or net worth of €35.35 million as of October 2, 2026. Its market cap has decreased by -51.25% in one year.
Market Cap
35.35M
Enterprise Value
36.29M
Revenue
10.53M
Ranking
n/a
PE Ratio
17.88
Stock Price
€2.20
ChartMarket Cap Chart
Since November 17, 2000, ABL Texcell Diagnostics's market cap has increased from 2.51M to 35.35M, an increase of 1,309.54%. That is a compound annual growth rate of 10.76%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 35.35M | -26.87% |
| Dec 31, 2025 | 48.34M | 21.95% |
| Dec 31, 2024 | 39.64M | -74.64% |
| Dec 29, 2023 | 156.30M | 3,819.50% |
| Dec 30, 2021 | 3.99M | 34.75% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sanofi | 87.58B |
| EssilorLuxottica Société anonyme | 66.46B |
| Sartorius Stedim Biotech | 20.06B |
| Eurofins Scientific SE | 12.94B |
| Adocia | 44.02M |
| Fermentalg | 43.90M |
| Klea Holding | 42.30M |
| S.M.A.I.O | 38.08M |